Transcriptional changes in Toxoplasma gondii in response to treatment with monensin

BACKGROUND: Infection with the apicomplexan protozoan parasite T. gondii can cause severe and potentially fatal cerebral and ocular disease, especially in immunocompromised individuals. The anticoccidial ionophore drug monensin has been shown to have anti-Toxoplasma gondii properties. However, the c...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhai, Bintao, He, Jun-Jun, Elsheikha, Hany M., Li, Jie-Xi, Zhu, Xing-Quan, Yang, Xiaoye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029487/
https://www.ncbi.nlm.nih.gov/pubmed/32070423
http://dx.doi.org/10.1186/s13071-020-3970-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029487/
https://www.ncbi.nlm.nih.gov/pubmed/32070423
http://dx.doi.org/10.1186/s13071-020-3970-1

Ejemplares similares